Published in full on NORML.
The oral administration of the non-psychotropic cannabis plant constituent cannabidiol (CBD) is safe and well tolerated in humans, according to clinical trial data published online by the journal Current Pharmaceutical Design.
Investigators at Kings College in London assessed the physiological and behavioral effects of CBD and THC versus placebo in 16 healthy volunteers in a randomized, double-blind, crossover trial.
Investigators reported that the oral administration of 10 mg of THC was associated with various physiological and behavioral effects—such as increased heart rate and sedation—whereas the oral administration of 600 mg of CBD was not.
This piece was reprinted by Project CBD with permission. It may not be reproduced in any form without approval from the source.
There is no single ratio or strain that’s right for everyone. A person’s sensitivity to THC is a key factor in determining the appropriate ratio and dosage of CBD-rich medicine. You need to find the combination of CBD and THC that works best for you.
Low-dose and high-dose treatments, protocols for chronic users, and the potential benefits of psychoactivity.
THC and other cannabinoids are known to induce neurogenesis — the creation of new neurons — in the brain. There are reasons to believe that this can positively influence diseases like dementia or traumatic brain injury, as well as the ability to learn. Malaysian researchers recently probed the question, does THC improve cognition by inducing neurogenesis? Yes, but only at the right dose.